January marks Glaucoma Awareness Month, in order to shed light on a silent threat to vision. The purpose of this month is to educate and encourage individuals to prioritize eye health, emphasizing the importance of early detection and intervention in managing glaucoma.

Glaucoma is often called “the silent thief of sight” and it affects over 60 million people worldwide. It is estimated that nearly half of those with glaucoma are unaware of their condition. As a leading cause of irreversible blindness, glaucoma poses a significant public health challenge. However, awareness and proactive measures can make a substantial difference.

Glaucoma typically develops gradually, often without noticeable symptoms in the early stages. Vision loss starts from the periphery, making it challenging to detect. As the condition progresses, individuals may experience tunnel vision, eye pain, headaches, and blurred vision. Regular eye check-ups are crucial for early detection, especially for those at higher risk due to age, family history, or other health conditions.

While glaucoma has no cure, early detection allows for effective management to slow its progression and preserve vision. Treatment options include prescription eye drops, oral medication, laser therapy, or surgery in advanced cases. Timely intervention can prevent or minimize vision loss, underscoring the importance of regular eye examinations as a proactive step in maintaining eye health.

GCT is an expert in conducting Ophthalmology clinical trials, please contact us at bd@gctrials.com to learn more.